Ocular Therapeutix Inc.

NASDAQ: OCUL · Real-Time Price · USD
12.60
-0.05 (-0.40%)
At close: Aug 15, 2025, 3:59 PM
12.80
1.59%
After-hours: Aug 15, 2025, 07:10 PM EDT

Ocular Therapeutix Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
63.72M 58.44M 51.49M 43.52M
Cost of Revenue
5.63M 5.28M 4.54M 4.41M
Gross Profit
58.1M 53.16M 46.95M 39.12M
Operating Income
-171.78M -82.38M -78.65M -78.04M
Interest Income
20.28M 3.98M 798K 33K
Pretax Income
-193.51M -80.74M -71.04M -6.55M
Net Income
-193.51M -80.74M -63.42M -10.8M
Selling & General & Admin
102.24M 74.49M 72.15M 67.07M
Research & Development
127.64M 61.05M 53.46M 50.08M
Other Expenses
n/a n/a -1K 1K
Operating Expenses
229.88M 135.54M 125.61M 117.15M
Interest Expense
13.58M 11.34M 7.02M 6.67M
Selling & Marketing Expenses
41.59M 40.55M 39.92M 35.19M
Cost & Expenses
235.5M 140.82M 130.15M 121.56M
Income Tax Expense
n/a n/a -7.62M 4.25M
Shares Outstanding (Basic)
158.26M 79.83M 76.88M 76.39M
Shares Outstanding (Diluted)
158.26M 85.6M 76.88M 82.16M
EPS (Basic)
-1.22 -1.09 -0.83 -0.14
EPS (Diluted)
-1.22 -1.02 -0.83 -0.13
EBITDA
-176.14M -66.42M -61.91M -75.62M
EBIT
-179.93M -69.4M -64.02M 118K
Depreciation & Amortization
3.79M 2.98M 2.11M 2.42M